Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010491 · ClinicalTrials.gov registry record · Phase 2
Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients
A Phase 2 study of HIV Infections, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00010491: Completed Phase 2 study of HIV Infections, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00010491 is a Phase 2 study of HIV Infections that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00010491, a Phase 2 study of HIV Infections, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
The objective of this study is to test alternative treatment strategies to reduce the frequency of chronic diarrhea among HIV positive individuals. 60 percent of patients with HIV disease in the U.S. will have diarrhea at some point in their illness. Although in general many of the opportunistic infections (OI's) associated with HIV have decreased due to new "drug cocktails", many of these drugs, however, have diarrhea as a side effect. In Asian countries, acupuncture (including moxibustion) has been widely used for the treatment of various gastrointestinal (GI) disorders. However, there are no published studies that test treatment protocols using acupuncture or moxibustion on patients with HIV experiencing chronic diarrhea.
Conditions Studied
Interventions
- PROCEDURE Acupuncture
- PROCEDURE Moxibustion
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2003-08 |
| Phase | Phase 2 |
What the finished NCT00010491 record still lists
NCT00010491 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.
NCT00010491 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00010491 about?
NCT00010491 is a clinical study titled "Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients". The objective of this study is to test alternative treatment strategies to reduce the frequency of chronic diarrhea among HIV positive individuals. 60 percent of patients with HIV disease in the U.S. will have diarrhea at some point in their illness. Although in general many of the opportunistic inf...
What is the current status of trial NCT00010491?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-09. Estimated completion is 2003-08.
What conditions does trial NCT00010491 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00010491?
The interventions under investigation include: Acupuncture (PROCEDURE), Moxibustion (PROCEDURE).
Who is sponsoring clinical trial NCT00010491?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00010491 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RECRUITING · Phase 2
-
Imaging Immune Activation in HIV by PET-MR
RECRUITING · Phase 2
-
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia